E

ENCell Co Ltd
KOSDAQ:456070

Watchlist Manager
ENCell Co Ltd
KOSDAQ:456070
Watchlist
Price: 16 270 KRW -6.01% Market Closed
Market Cap: 177.3B KRW

Net Margin
ENCell Co Ltd

-312.8%
Current
-227%
Average
1.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-312.8%
=
Net Income
-18.2B
/
Revenue
5.8B

Net Margin Across Competitors

No Stocks Found

ENCell Co Ltd
Glance View

ENCell Co Ltd is a KR-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-08-23. ENCell Co Ltd is a Korea-based company principally engaged in the development and research of new drugs. The firm is principally engaged in the development and research of cell and gene-based biopharmaceuticals. The firm is also engaged in the provision of biopharmaceutical quality testing services. In addition, the Company is engaged in the biopharmaceutical consignment production business.

Intrinsic Value
1 314.7 KRW
Overvaluation 92%
Intrinsic Value
Price
E
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-312.8%
=
Net Income
-18.2B
/
Revenue
5.8B
What is the Net Margin of ENCell Co Ltd?

Based on ENCell Co Ltd's most recent financial statements, the company has Net Margin of -312.8%.

Back to Top